Related references
Note: Only part of the references are listed.Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells
Zhang-Xu He et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
HDAC6 as privileged target in drug discovery: A perspective
Sravani Pulya et al.
PHARMACOLOGICAL RESEARCH (2021)
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
Xin-Hui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition
Arshdeep Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer
Jie Sun et al.
FEBS JOURNAL (2020)
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6
Jeremy D. Osko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo
Ritu Ojha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation
Kseniya Ustinova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity
Xiaoyang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Flavia Alves Verza et al.
CANCERS (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Aggresomal sequestration and STUB1-mediated ubiquitylation during mammalian proteaphagy of inhibited proteasomes
Won Hoon Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cortactin deacetylation by HDAC6 and SIRT2 regulates neuronal migration and dendrite morphogenesis during cerebral cortex development
Ji-ye Kim et al.
MOLECULAR BRAIN (2020)
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Guo Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
An insight on medicinal attributes of 1,2,4-triazoles
Ranjana Aggarwal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Yan Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5-a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction
Shuai Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1 / KDM1A inhibitors
Shuai Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Antibacterial activity study of 1,2,4-triazole derivatives
Feng Gao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases
Nicholas J. Porter et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors
Katharina Voegerl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A
William Doherty et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literature
Zachary T. Rivers et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of Na(v)1.7 inhibition
Alessandro A. Boezio et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer
Jing Dong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Histone deacetylase 6 in cancer
Ting Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors
Rob De Vreese et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect
Kahia Messaoudi et al.
NATURE COMMUNICATIONS (2017)
Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense
Ya Gao et al.
ONCOTARGET (2017)
Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Ramandeep Kaur et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
The importance of triazole scaffold in the development of anticonvulsant agents
Adile Ayati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Inside HDACs with more selective HDAC inhibitors
Joelle Roche et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia
Jesse J. McClure et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Xianping Lu et al.
INTRACTABLE & RARE DISEASES RESEARCH (2016)
HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer
Se Jin Park et al.
CANCER LETTERS (2014)
Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a] phthalazine derivatives
Deng-Qi Xue et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development of a histone deacetylase 6 inhibitor and its biological effects
Ju-Hee Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Berkley E. Gryder et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Pan-Histone Deacetylase Inhibitor Panobinostat Sensitizes Gastric Cancer Cells to Anthracyclines via Induction of CITED2
Ivonne Regel et al.
GASTROENTEROLOGY (2012)
Structural Basis for Sirtuin Activity and Inhibition
Hua Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
R. B. Parmigiani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Share Paper
